These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3098703)

  • 1. Tissue-type plasminogen activator: a new fibrinolytic agent.
    Milligan KS
    Heart Lung; 1987 Jan; 16(1):69-74. PubMed ID: 3098703
    [No Abstract]   [Full Text] [Related]  

  • 2. New thrombolytic drugs in acute myocardial infarction: theoretical and practical considerations.
    Verstraete M
    Circulation; 1987 Aug; 76(2 Pt 2):II31-8. PubMed ID: 3111745
    [No Abstract]   [Full Text] [Related]  

  • 3. Thrombolytic agents for acute evolving myocardial infarction: comparative effects.
    Sherry S
    Ration Drug Ther; 1987 Jan; 21(1):1-9. PubMed ID: 3112866
    [No Abstract]   [Full Text] [Related]  

  • 4. Tissue-plasminogen activator: a new drug in reperfusion therapy (continuing education credit).
    Strauss E; Rudy EB
    Crit Care Nurse; 1986; 6(3):30-5, 38-43. PubMed ID: 3089687
    [No Abstract]   [Full Text] [Related]  

  • 5. Thrombolytic therapy in acute myocardial infarction.
    Smucker DR; Burket MW
    Am Fam Physician; 1988 May; 37(5):265-74. PubMed ID: 3129924
    [No Abstract]   [Full Text] [Related]  

  • 6. Thrombolytic therapy update.
    Sipperly ME
    Crit Care Nurse; 1985; 5(6):30-4. PubMed ID: 3936680
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibrinolysis and activators of plasminogen.
    Sobel BE
    Heart Lung; 1987 Nov; 16(6 Pt 2):775-9. PubMed ID: 3119522
    [No Abstract]   [Full Text] [Related]  

  • 8. Thrombolytic agents in clinical medicine.
    Verstraete M
    Adv Intern Med; 1988; 33():119-41. PubMed ID: 3125722
    [No Abstract]   [Full Text] [Related]  

  • 9. [Thrombolytic treatment for acute myocardial infarction].
    Tranchesi Júnior B
    AMB Rev Assoc Med Bras; 1989; 35(4):159-63. PubMed ID: 2518083
    [No Abstract]   [Full Text] [Related]  

  • 10. Myocardial salvage: thrombolytic therapy.
    Sternbach G; Tintinalli JE
    Emerg Med Clin North Am; 1988 May; 6(2):351-9. PubMed ID: 3127194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of fibrinolytic therapy for ST-segment-elevation acute myocardial infarction.
    Van de Werf FJ; Topol EJ; Sobel BE
    J Thromb Haemost; 2009 Jan; 7(1):14-20. PubMed ID: 19090814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary thrombolysis: practical considerations.
    Eisenberg PR; Jaffe AS
    Cardiol Clin; 1987 Feb; 5(1):129-41. PubMed ID: 3103918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New thrombolytic agents in myocardial infarction].
    Charbonnier B; Lang M; Brochier M
    Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non neutralizing antibodies to tissue type plasminogen activator in the serum of acute myocardial infarction patients treated with the recombinant protein.
    Cugno M; Cicardi M; Colucci M; Bisiani G; Merlini PA; Spinola A; Paonessa R; Agostoni A
    Thromb Haemost; 1996 Aug; 76(2):234-8. PubMed ID: 8865537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From thrombolytic megatrials to clinical policy-making: facing the facts.
    Naylor CD; Armstrong PW
    Can J Cardiol; 1995 Jun; 11(6):472-6. PubMed ID: 7780867
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thrombolytic treatment of acute myocardial infarct. 1].
    Soares-Costa JT; Soares-Costa TJ; Gabriel HM
    Acta Med Port; 1998 May; 11(5):409-19. PubMed ID: 9951051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte growth factor plasma levels after myocardial infarction are not affected by recombinant tissue-type plasminogen-activator therapy.
    Molnar C; Buratti T; Wiedermann CJ; Tilg H
    Eur Cytokine Netw; 2000 Mar; 11(1):87-90. PubMed ID: 10705304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical pharmacology and therapeutic aspects of thrombolytic agents.
    Fears R
    Pharmacol Rev; 1990 Sep; 42(3):201-22. PubMed ID: 2120714
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experience with the thrombolytic therapy of myocardial infarct].
    Gospodarenko AL; Ardashev VN; Tiurin VP; Chernetsov VA; Iakovlev VB; Vrublevskiĭ OIu; Makarenko AS; Sokolianskiĭ NV; Chernov SA; Kucherov VV; Davrent'eva TA
    Voen Med Zh; 1997 Nov; 318(11):40-5. PubMed ID: 9461835
    [No Abstract]   [Full Text] [Related]  

  • 20. [Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study].
    Franzosi MG
    Ital Heart J Suppl; 2001 Sep; 2(9):1034-6. PubMed ID: 11675828
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.